Systematic reviews and guidelines for oral complications of cancer therapies: Current challenges and future opportunities

Supportive Care in Cancer

Volumn 18, Issue 8, 2010, Pages 977-978

  Brennan, Michael T ^a   Spijkervet, Fred K L ^b   Elting, Linda S ^c  

^a CAROLINAS MEDICAL CENTER   (United States)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; CANCER THERAPY; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DYSGEUSIA; ECONOMIC ASPECT; EDITORIAL; HUMAN; MOUTH DISEASE; MOUTH INFECTION; MOUTH PAIN; MYCOSIS; OUTCOME ASSESSMENT; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT RESPONSE; XEROSTOMIA;

HUMANS; MOUTH DISEASES; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE;

EID: 77956479342     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-010-0855-4     Document Type: Editorial

References (6)

1. U. S. Cancer Statistics Working Group. United States cancer statistics: 2001 incidence and mortality. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute (2004), pp 1-699
2. (2005) World Health Organization: Cancer [cited Sep. 26]:. Available from http://www.who.int/cancer/en/.
3. U. S. Department of Health and Human Services. Oral Health in America: A Report of the Surgeon General, Executive Summary (2000) Rockville. U. S. Department of Health and Human Services, National Institute of Dental and Craniofacial Research, National Institutes of Health, MD
4. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB, for the Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100:1995-2025
5. Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST, for the Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology (2004) Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100:2026-2046
6. Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T, Shea T, Yanovich S, Hansen K, Noga S, McCarty J, LeMaistre CF, Sung EC, Blazar BR, Elhardt D, Chen M, Emmanouilides C (2004) Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351:2590-2598